These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13696747)

  • 21. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
    Yalaoui S
    Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic aspects of rheumatoid arthritis].
    Dieudé P
    Rev Prat; 2005 Dec; 55(19):2143-5. PubMed ID: 16594119
    [No Abstract]   [Full Text] [Related]  

  • 23. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
    Bouffi C; Djouad F; Mathieu M; Noël D; Jorgensen C
    Rheumatology (Oxford); 2009 Oct; 48(10):1185-9. PubMed ID: 19561159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination of dexamethasone and methandrostenolone in rheumatoid arthritis].
    CARUSO AC; GRAMAJO RJ; MARRONE JM
    Sem Med; 1962 Nov; 121():1893-7. PubMed ID: 14018991
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dexamethasone-methandro-stenolone associated in rheumatoid arthritis].
    CARUSO AC; GRAMAJO RJ
    Sem Med; 1963 May; 122():985-8. PubMed ID: 14018992
    [No Abstract]   [Full Text] [Related]  

  • 26. Autoantibodies in rheumatoid arthritis: a review.
    Mewar D; Wilson AG
    Biomed Pharmacother; 2006 Dec; 60(10):648-55. PubMed ID: 17064873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ANA+ (anti-nuclear antibody) is correlated with RF+ (rheumatoid factor) in rheumatoid arthritis.
    Matsos MP; Pope JE; Spencer-Green G
    Inflammopharmacology; 2004; 12(3):229-31. PubMed ID: 15527547
    [No Abstract]   [Full Text] [Related]  

  • 28. From immunohistochemistry to pathophysiology of rheumatoid arthritis: cross reactivity of self anti-immunoglobulin antibodies with collagen(s) may contribute to mechanisms of connective tissue damage (a hypothesis).
    Rowiński J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():182-4. PubMed ID: 15638416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines in the pathogenesis of rheumatoid arthritis.
    McInnes IB; Schett G
    Nat Rev Immunol; 2007 Jun; 7(6):429-42. PubMed ID: 17525752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic humoral autoimmunity but joint-specific inflammation: the syndrome of rheumatoid arthritis.
    Wu X; Shih F; Atkinson JP
    Arthritis Rheum; 2007 Sep; 56(9):2823-8. PubMed ID: 17763409
    [No Abstract]   [Full Text] [Related]  

  • 31. The hemagglutination test for rheumatoid arthritis. IV. Characterization of the rheumatoid agglutinating factors by analysis of serum fractions prepared by ethanol fractionation.
    HELLER G; KOLODNY MH; LEPOW IH; JACOBSON AS; RIVERA ME; MARKS GH
    J Immunol; 1955 May; 74(5):340-50. PubMed ID: 14367821
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoimmunity and rheumatoid arthritis.
    Smolen JS; Hayer S; Schett G; Redlich K; Aringer M; Kollias G; Wagner E; Steiner G
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S23. PubMed ID: 15309784
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
    Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological reactions to polysaccharides in rheumatoid arthritis.
    GOFTON JP; THOMAS JW; ROBINSON HS
    Can Med Assoc J; 1957 Dec; 77(12):1098-102. PubMed ID: 13489605
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prognostic value of serological rheumatic reactions].
    MENDES DE LEON C; DE MENDES DE LEON
    Ned Tijdschr Geneeskd; 1959 May; 103(18):984-5. PubMed ID: 13657253
    [No Abstract]   [Full Text] [Related]  

  • 36. [The new serological markers of rheumatoid arthritis].
    Tuchocka-Piotrowska A; Puszczewicz M
    Pol Merkur Lekarski; 2007 Sep; 23(135):215-20. PubMed ID: 18080699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The serological aspects of diffuse mesenchymal reactions].
    ENDERLIN M
    Schweiz Med Wochenschr; 1960 Sep; 90():1017-21. PubMed ID: 13696747
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic manifestations of rheumatoid arthritis (rheumatoid disease) accentuated by steroid therapy.
    PAUL WD
    J Iowa State Med Soc; 1961 Apr; 51():205-16. PubMed ID: 13733461
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.